Pēd. atjaunots: 01.07.2024 17:59 (GMT+3)

Farmaatsiatehas: Commentary to the financial results 03/99

28.04.1999, Tallinna Farmaatsiatehas, TLN
TALLINNA FARMAATSIATEHASE AS
ANNOUNCEMENT
28.04.99

COMMENTARY TO THE UNAUDITED FINANCIAL RESULTS OF Q1 1999

The Q1 1999 net sales of Tallinna Farmaatsiatehase AS amounted to 16.7
million EEK. Compared to the respective figure of the last year, it is
approximately two times lower, accounting for 52.7% of the last year’s
turnover. The main factor behind the decreased turnover figure is the
same as for many other Estonian companies – the main emphasis was
placed on the Eastern market, which are currently undergoing the
financial crisis.

When TFT exported finished goods in 1998 for 26.7 million EEK, then the
same figure in Q1 1999 was 11.6 million EEK. At the same time, the
company’s sales in Estonia increased, accounting in Q1 1999 for 34% or
5.2 million EEK of net sales (in Q1 1998, the respective figure was
only 14.5%, or 4.6 million EEK).

As a result of active sales policies and effective cost management, TFT
AS ended Q1 with a profit of 1 million EEK. The respective result of Q1
1998 was a profit of 2.1 million EEK.

In order to manage the company profitably, TFT works in two ways.
First, it stimulates sales support activities in the Baltic countries
in cooperation with Grindex. Secondly, TFT continues to conform the
management and operating expenses to lower production volumes. Compared
to Q1 1998, TFT has managed to cut costs mainly on the account of
operating expenses (by ca ~2.0 million EEK). The personnel expenses
were decreased from the last year by 27%.

The company currently employs 202 people.

In May 1999, Tallinna Farmaatsiatehase AS will celebrate its 85th
anniversary.


Arno Kaseniit
Member of the Management Board
Tel: +372 61 20 201

Vērtspapīri

Akcijas
Obligācijas
Ieguldījumu Fondi

Tirgus informācija

Statistika
Tirdzniecība
Indeksi
Izsoles

Noteikumi

Biržas noteikumi
Uzraudzība

Nāc uz Biržu

Uzņēmumiem
Investoriem
Biržas biedriem
First North konsultantiem

Aktualitātes

Nasdaq ziņas
Emitentu ziņas
Kalendārs

Par mums

Nasdaq Baltijas tirgus
Biroji